{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:25:50Z","timestamp":1784280350334,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05086-9","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T12:45:48Z","timestamp":1755693948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical significance and regulatory mechanism of miR-134-5p in rheumatic heart disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Liangqin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"9819","key":"5086_CR1","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(11)61171-9","volume":"379","author":"E Marijon","year":"2012","unstructured":"Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012;379(9819):953\u201364.","journal-title":"Lancet"},{"issue":"1","key":"5086_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12916-023-02925-4","volume":"21","author":"J Sun","year":"2023","unstructured":"Sun J, Qiao Y, Zhao M, Magnussen CG, Xi B. Global, regional, and National burden of cardiovascular diseases in youths and young adults aged 15\u201339 years in 204 countries\/territories, 1990\u20132019: a systematic analysis of global burden of disease study 2019. BMC Med. 2023;21(1):222.","journal-title":"BMC Med"},{"issue":"1","key":"5086_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1186\/s12872-023-03552-w","volume":"23","author":"L Shi","year":"2023","unstructured":"Shi L, Bao C, Wen Y, Liu X, You G. Analysis and comparison of the trends in burden of rheumatic heart disease in China and worldwide from 1990 to 2019. BMC Cardiovasc Disord. 2023;23(1):517.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"5086_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrcardio.2012.157","volume":"10","author":"K Roberts","year":"2013","unstructured":"Roberts K, Colquhoun S, Steer A, Rem\u00e9nyi B, Carapetis J. Screening for rheumatic heart disease: current approaches and controversies. Nat Rev Cardiol. 2013;10(1):49\u201358.","journal-title":"Nat Rev Cardiol"},{"key":"5086_CR5","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.2147\/IDR.S376401","volume":"15","author":"A Ahmed Abdelmaksoud","year":"2022","unstructured":"Ahmed Abdelmaksoud A, Nafady A, Ezzeldin Sayed Bazeed S, Khalefa M, Elsamman MK, Abdelrhman Sayed MA, Qubaisy HM, Ghweil AA, Aref ZF. Lactoferrin versus long-acting penicillin in reducing elevated anti-streptolysin O titer in cases of tonsillopharyngitis. Infect Drug Resist. 2022;15:5257\u201363.","journal-title":"Infect Drug Resist"},{"issue":"10","key":"5086_CR6","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.6026\/973206300181041","volume":"18","author":"RV G","year":"2022","unstructured":"G RV. Prevalence of hs-CRP among Indians with hypertension. Bioinformation. 2022;18(10):1041\u20133.","journal-title":"Bioinformation"},{"issue":"2","key":"5086_CR7","first-page":"429","volume":"45","author":"A Chen","year":"2020","unstructured":"Chen A, Wen J, Lu C, Lin B, Xian S, Huang F, Wu Y, Zeng Z. Inhibition of miR\u2013155\u20135p attenuates the valvular damage induced by rheumatic heart disease. Int J Mol Med. 2020;45(2):429\u201340.","journal-title":"Int J Mol Med"},{"issue":"6","key":"5086_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24487","volume":"36","author":"X Zhang","year":"2022","unstructured":"Zhang X, Gao Y, Wu H, Mao Y. Hsa_circ_0003748 promotes disease progression in rheumatic valvular heart disease by sponging miR-577. J Clin Lab Anal. 2022;36(6): e24487.","journal-title":"J Clin Lab Anal"},{"key":"5086_CR9","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.12659\/MSM.893540","volume":"21","author":"H Dong","year":"2015","unstructured":"Dong H, Sun Y, Shan F, Sun Q, Yang B. Down-regulation of miR-101 contributes to rheumatic heart disease through up-regulating TLR2. Med Sci Monitor: Int Med J Experimental Clin Res. 2015;21:1500\u20136.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"issue":"1","key":"5086_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12872-018-0788-2","volume":"18","author":"Q Lu","year":"2018","unstructured":"Lu Q, Sun Y, Duan Y, Li B, Xia J, Yu S, Zhang G. Comprehensive MicroRNA profiling reveals potential augmentation of the IL1 pathway in rheumatic heart valve disease. BMC Cardiovasc Disord. 2018;18(1):53.","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"5086_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102116","volume":"298","author":"M Huang","year":"2022","unstructured":"Huang M, Wang Y, Wang Z, Qin Q, Zhang H, Liu S, Cui J, Zhang Y, Jiang X, Xu L. MiR-134-5p inhibits osteoclastogenesis through a novel miR-134-5p\/Itgb1\/MAPK pathway. J Biol Chem. 2022;298(7): 102116.","journal-title":"J Biol Chem"},{"issue":"10","key":"5086_CR12","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/iub.2351","volume":"72","author":"M Lu","year":"2020","unstructured":"Lu M, Qin X, Yao J, Yang Y, Zhao M, Sun L. MiR-134-5p targeting XIAP modulates oxidative stress and apoptosis in cardiomyocytes under hypoxia\/reperfusion-induced injury. IUBMB Life. 2020;72(10):2154\u201366.","journal-title":"IUBMB Life"},{"issue":"3","key":"5086_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cardfail.2003.10.005","volume":"10","author":"SH Kubo","year":"2004","unstructured":"Kubo SH, Schulman S, Starling RC, Jessup M, Wentworth D, Burkhoff D. Development and validation of a patient questionnaire to determine New York Heart Association classification. J Card Fail. 2004;10(3):228\u201335.","journal-title":"J Card Fail"},{"issue":"11 Suppl 1","key":"5086_CR14","first-page":"S222","volume":"126","author":"Q Zeng","year":"2012","unstructured":"Zeng Q, Jin C, Ao L, Cleveland JC Jr., Song R, Xu D, Fullerton DA, Meng X. Cross-talk between the Toll-like receptor 4 and Notch1 pathways augments the inflammatory response in the interstitial cells of stenotic human aortic valves. Circulation. 2012;126(11 Suppl 1):S222-230.","journal-title":"Circulation"},{"issue":"1","key":"5086_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s12872-023-03497-0","volume":"23","author":"B MacDonald","year":"2023","unstructured":"MacDonald B, Tarca A, Causer L, Maslin K, Bruce D, Schreiber-Wood R, Kumar M, Ramsay J, Andrews D, Budgeon C, et al. Left ventricular remodelling in rheumatic heart disease - trends over time and implications for follow-up in childhood. BMC Cardiovasc Disord. 2023;23(1):462.","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"5086_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jacc.2008.09.048","volume":"53","author":"A Shiran","year":"2009","unstructured":"Shiran A, Sagie A. Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol. 2009;53(5):401\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"5086_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12574-024-00663-x","volume":"22","author":"N Sari","year":"2024","unstructured":"Sari N, Soesanto AM. Right ventricular function in mitral stenosis: plays a fundamental role. J Echocardiogr. 2024;22(4):185\u201392.","journal-title":"J Echocardiogr"},{"issue":"8","key":"5086_CR18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cardfail.2013.06.001","volume":"19","author":"Y Jin","year":"2013","unstructured":"Jin Y, Wang HS, Wang ZW, Li XM, Yin ZT, Zhu Y. Risk factors for midterm cardiac function deterioration after valve replacement surgery in patients with rheumatic mitral stenosis. J Card Fail. 2013;19(8):565\u201370.","journal-title":"J Card Fail"},{"issue":"3","key":"5086_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4103\/0971-5916.198672","volume":"144","author":"KK Talwar","year":"2016","unstructured":"Talwar KK, Gupta A. Predictors of mortality in chronic rheumatic heart disease. Indian J Med Res. 2016;144(3):311\u20133.","journal-title":"Indian J Med Res"},{"issue":"1","key":"5086_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12872-021-02175-3","volume":"21","author":"Y Dadjo","year":"2021","unstructured":"Dadjo Y, Moshkani Farahani M, Nowshad R, Sadeghi Ghahrodi M, Moaref A, Kojuri J. Mid-term (up to 12 years) clinical and echocardiographic outcomes of percutaneous transvenous mitral commissurotomy in patients with rheumatic mitral stenosis. BMC Cardiovasc Disord. 2021;21(1):355.","journal-title":"BMC Cardiovasc Disord"},{"key":"5086_CR21","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.2147\/IDR.S362601","volume":"15","author":"X Zhang","year":"2022","unstructured":"Zhang X, Jin F, Lu Y, Ni F, Xu Y, Xia W. Clinical characteristics and risk factors for in-hospital mortality in 240 cases of infective endocarditis in a tertiary hospital in China: a retrospective study. Infect Drug Resist. 2022;15:3179\u201389.","journal-title":"Infect Drug Resist"},{"issue":"9","key":"5086_CR22","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41419-021-04111-x","volume":"12","author":"S Hao","year":"2021","unstructured":"Hao S, Sui X, Wang J, Zhang J, Pei Y, Guo L, Liang Z. Secretory products from epicardial adipose tissue induce adverse myocardial remodeling after myocardial infarction by promoting reactive oxygen species accumulation. Cell Death Dis. 2021;12(9):848.","journal-title":"Cell Death Dis"},{"key":"5086_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415812","author":"B Franczyk","year":"2022","unstructured":"Franczyk B, Gluba-Brz\u00f3zka A, Rysz-G\u00f3rzy\u0144ska M, Rysz J. The role of inflammation and oxidative stress in rheumatic heart disease. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232415812.","journal-title":"Int J Mol Sci"},{"key":"5086_CR24","doi-asserted-by":"publisher","first-page":"1331609","DOI":"10.3389\/fimmu.2024.1331609","volume":"15","author":"Y Xia","year":"2024","unstructured":"Xia Y, Gao D, Wang X, Liu B, Shan X, Sun Y, Ma D. Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets. Front Immunol. 2024;15:1331609.","journal-title":"Front Immunol"},{"issue":"5","key":"5086_CR25","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/HJH.0000000000003979","volume":"43","author":"LL Tang","year":"2025","unstructured":"Tang LL, Xu XY, Zhang M, Qin Q, Xue R, Jiang S, Yang X, Liang C, Wang QS, Yu CJ, et al. KAT7 contributes to ponatinib-induced hypertension by promoting endothelial senescence and inflammatory responses through activating NF-\u03baB signaling pathway. J Hypertens. 2025;43(5):827\u201340.","journal-title":"J Hypertens"},{"issue":"1","key":"5086_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s11658-022-00389-7","volume":"27","author":"WV Zheng","year":"2022","unstructured":"Zheng WV, Xu W, Li Y, Qin J, Zhou T, Li D, Xu Y, Cheng X, Xiong Y, Chen Z. Anti-aging effect of \u03b2-carotene through regulating the KAT7-P15 signaling axis, inflammation and oxidative stress process. Cell Mol Biol Lett. 2022;27(1):86.","journal-title":"Cell Mol Biol Lett"},{"issue":"3","key":"5086_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.36660\/abc.20200154","volume":"116","author":"NFA Gomes","year":"2021","unstructured":"Gomes NFA, Pascoal-Xavier MA, Passos LSA, Paula TMN, Aguiar JMS, Guar\u00e7oni FV, Nassif MCL, Gelape CL, Braulio R, Costa PHN, et al. Histopathological characterization of mitral valvular lesions from patients with rheumatic heart disease. Arquivos Brasileiros De Cardiologia. 2021;116(3):404\u201312.","journal-title":"Arquivos Brasileiros De Cardiologia"},{"issue":"5","key":"5086_CR28","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41419-021-03750-4","volume":"12","author":"L Zhang","year":"2021","unstructured":"Zhang L, He J, Wang J, Liu J, Chen Z, Deng B, Wei L, Wu H, Liang B, Li H, et al. Knockout RAGE alleviates cardiac fibrosis through repressing endothelial-to-mesenchymal transition (EndMT) mediated by autophagy. Cell Death Dis. 2021;12(5):470.","journal-title":"Cell Death Dis"},{"key":"5086_CR29","first-page":"1073","volume":"23","author":"KL Tong","year":"2024","unstructured":"Tong KL, Mahmood Zuhdi AS, Wong PF. The role of miR-134-5p in 7-ketocholesterol-induced human aortic endothelial dysfunction. EXCLI J. 2024;23:1073\u201390.","journal-title":"EXCLI J"},{"key":"5086_CR30","doi-asserted-by":"publisher","first-page":"114709","DOI":"10.1016\/j.intimp.2025.114709","volume":"157","author":"Z Wang","year":"2025","unstructured":"Wang Z, Chu R, Ge H, Zhu Z, Zhang R, Han D, Fang R, Wang N, Gao S, Wang Y, et al. GRK2-facilitated TLR4 signaling promotes cardiac fibrosis in rheumatic mice. Int Immunopharmacol. 2025;157:114709.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"5086_CR31","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/1440-1681.13155","volume":"46","author":"M Li","year":"2019","unstructured":"Li M, Xu S, Geng Y, Sun L, Wang R, Yan Y, Wang H, Li Y, Yi Q, Zhang Y, et al. The protective effects of L-carnitine on myocardial ischaemia-reperfusion injury in patients with rheumatic valvular heart disease undergoing CPB surgery are associated with the suppression of NF-\u03baB pathway and the activation of Nrf2 pathway. Clin Exp Pharmacol Physiol. 2019;46(11):1001\u201312.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"5086_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00109-025-02519-y","volume":"103","author":"Z Liu","year":"2025","unstructured":"Liu Z, Qiu L, Zhang Y, Zhao G, Sun X, Luo W. Kat7 accelerates osteoarthritis disease progression through the TLR4\/NF-\u03baB signaling pathway. J Mol Med. 2025;103(3):273\u201384.","journal-title":"J Mol Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05086-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05086-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05086-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:09:55Z","timestamp":1757408995000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05086-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5086"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05086-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. All subjects or their families accepted this study objective and signed the informed consent. The Ethics Committee of Shaanxi Provincial Hospital of Integrated Traditional Chinese and Western Medicine, also approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"618"}}